Cargando…

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth

BACKGROUND: Ketamine is an emerging treatment for treatment-resistant depression (TRD) associated with rapid and robust improvements in depressive symptoms and suicidality. However, the efficacy and safety of ketamine in transitional age youth (TAY; age 18–25) populations remains understudied. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chisamore, Noah, Danayan, Kevork, Rodrigues, Nelson B, Di Vincenzo, Joshua D, Meshkat, Shakila, Doyle, Zoe, Mansur, Rodrigo, Phan, Lee, Fancy, Farhan, Chau, Edmond, Tabassum, Aniqa, Kratiuk, Kevin, Arekapudi, Anil, McIntyre, Roger S, Rosenblat, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399094/ https://www.ncbi.nlm.nih.gov/pubmed/37194253 http://dx.doi.org/10.1177/02698811231171531

Ejemplares similares

Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic
por: Rosenblat, Joshua D., et al.
Publicado: (2021)

Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic Review
por: Di Vincenzo, Joshua Daniel, et al.
Publicado: (2023)

Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023)

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2023)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
por: Rosenblat, Joshua D., et al.
Publicado: (2017)

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
por: McIntyre, Roger S, et al.
Publicado: (2022)

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)
por: Rosenblat, Joshua D., et al.
Publicado: (2023)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs
por: Kaka, Ubedullah, et al.
Publicado: (2016)

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
por: Woo, Young Sup, et al.
Publicado: (2016)

Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis
por: Lee, Yena, et al.
Publicado: (2022)

Utilization of Psychiatric Team Driven Ketamine Infusions
por: Ithman, M., et al.
Publicado: (2022)

Increased Demand for Ketamine Infusions and Associated Complexities
por: Peskin, Evan, et al.
Publicado: (2023)

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study
por: Gutierrez, Gilmar, et al.
Publicado: (2022)

Suicide prevention and ketamine: insights from computational modeling
por: Charlton, Colleen E., et al.
Publicado: (2023)

Effect of intraoperative infusion of ketamine on remifentanil-induced hyperalgesia
por: Choi, Eunji, et al.
Publicado: (2015)

Improvement of Cyclic Vomiting Syndrome with Outpatient Ketamine Infusions
por: Carpenter, Anna, et al.
Publicado: (2021)

Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction
por: McIntyre, Roger S, et al.
Publicado: (2021)

Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
por: Siegel, Joshua S., et al.
Publicado: (2021)

Ketamine infusion as a sedative-analgesic in severe ARDS (KISS)
por: Pata, Ramakanth, et al.
Publicado: (2021)

Antisuicidal efficacy of ketamine infusion in suicidal patients of depressive disorder
por: Pathak, Umesh, et al.
Publicado: (2021)

Continuous Ketamine Infusion as a Treatment for Refractory Facial Pain
por: Garcia, Roxana, et al.
Publicado: (2023)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Low-Dose Ketamine Infusion Versus Morphine Infusion During Abdominoplasty to Change the Postoperative Pain Profile
por: Ali, Hassan, et al.
Publicado: (2020)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

The comparison of the effects of intravenous ketamine or dexmedetomidine infusion on spinal block with bupivacaine
por: Kim, Myoung-Hun, et al.
Publicado: (2014)

Effect of intraoperative infusion of low-dose ketamine on management of postoperative analgesia
por: Kaur, Sarvjeet, et al.
Publicado: (2015)

Effects of continuous ketamine infusion on hemodynamics and mortality in critically ill children
por: Park, Sojin, et al.
Publicado: (2019)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
por: Rosenblat, Christian, et al.
Publicado: (2015)

COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
por: Ceban, Felicia, et al.
Publicado: (2023)

Safety and efficacy of ketamine infusion in late onset depression, and conversion to treatment response
por: Srivastava, Shrikant, et al.
Publicado: (2015)

Rapid Resolution of Grief with IV Infusion of Ketamine: A Unique Phenomenological Experience
por: Gowda, Mahesh Ramanna, et al.
Publicado: (2016)

Ischemic Postconditioning and Subanesthetic S(+)-Ketamine Infusion: Effects on Renal Function and Histology in Rats
por: de Resende, Marco A. C., et al.
Publicado: (2015)

Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis
por: MacMahon, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uui4j00kjp6bnk6cfbe8uu5qco